1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Meinian Onehealth Healthcare Holdings Co., Ltd.

Meinian Onehealth Healthcare Holdings Co., Ltd.

002044.SZ
Meinian Onehealth Healthcare Holdings Co., Ltd.CN flagShenzhen Stock Exchange
4.39
CNY
-0.36
- -
17.18BMarket Cap
Meinian Onehealth Healthcare Holdings Co., Ltd.
002044.SZ
(Shenzhen Stock Exchange)

Recent

price

4.39

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.67
0.96
0.86
1.04
0.71
0.73
1.13
1.7
2.27
2.26
1.99
2.99
2.16
2.8
2.65
2.54
2.02
Revenue per Share
0.03
0.07
0.08
-0.01
0.07
0.09
0.12
0.16
0.22
-0.23
0.14
0.02
-0.14
0.13
0.07
0.07
0.01
Basic EPS, GAAP
-0.04
-0.01
0.08
0.01
-0.02
-0.01
0.09
0.14
0.19
0.22
0.17
0.53
0.28
0.42
0.3
0.34
-0.08
Free Cash Flow per Basic Share
0.02
0.01
0.03
0.07
- -
0.01
0.01
0.03
0.1
0.14
0.1
0.05
0.03
0.04
0.05
0.05
0.03
Dividend per Share
0.26
0.39
0.42
0.36
0.5
0.6
0.88
1.1
1.43
1.35
1.43
1.84
1.23
1.35
1.35
1.38
1.48
Book Value per Share
0.4
0.44
0.7
0.53
0.68
0.98
0.65
0.77
0.67
1.03
1.14
1.46
0.86
0.89
0.8
0.81
0.83
Tangible Book Value per Share
829
809
811
742
2,018
2,883
3,826
3,688
3,730
3,767
3,936
3,079
3,993
3,889
4,032
4,076
3,643
Basic Weighted Avg Shares
554
776
701
769
1,431
2,101
4,314
6,282
8,458
8,525
7,848
9,216
8,616
10,894
10,702
10,360
7,373
Sales/Revenue/Turnover
5.59
10.71
13.48
11.1
11.91
15.51
15.08
14.46
16.25
12.34
5.38
8.45
0.84
11.2
10.35
10.12
8.23
Operating Margin (%)
12
12
13
16
55
77
154
215
317
400
408
1,075
1,166
1,202
1,224
1,198
- -
Depreciation Expense
23
59
66
-6
140
260
452
584
821
-866
551
62
-559
506
282
285
32
Net Income, GAAP
24.74
26.19
25.71
- -
18.28
20.27
21.51
24.64
24.21
- -
18.11
56.36
- -
21.13
30.97
33.52
59.74
Effective Tax Rate (%)
4.19
7.59
9.4
-0.81
9.79
12.39
10.47
9.3
9.7
-10.16
7.02
0.67
-6.49
4.64
2.64
2.75
0.44
Profit Margin (%)
241
200
339
175
503
785
373
167
-848
708
-798
-1,150
-2,274
-1,723
-1,899
-1,429
-1,642
Working Capital
- -
- -
52
22
4
86
245
1,000
2,250
2,551
4,195
3,007
2,380
2,479
2,446
2,066
2,031
LT Debt
348
396
602
427
1,494
3,242
6,192
7,012
7,390
8,154
8,672
8,778
8,102
8,410
8,703
8,932
8,664
Total Equity
6.68
16.33
13.14
- -
11.67
9.16
8.94
7.99
9.2
- -
2.12
2.14
- -
7.24
5.42
4.68
1.65
Return on Invested Capital (%)
9.18
20.48
14.43
- -
15.49
12.84
11.69
10.2
9.17
- -
5.46
0.86
- -
5.17
3.11
3.21
0.81
Return on Capital (%)
10.89
22.29
20.1
-2.04
22.02
18.97
17.64
15.68
17.45
-16.6
10.27
1.09
-10.58
9.95
5.28
5.15
0.61
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
4,030
3,924
LT Borrowings
- -
132
165
LT Finance Leases
- -
1,934
1,866
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
3,914
3,914
Market Capitalization
19,549
20,768
20,512

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
- -
7,401
6,254
Cash, Cash Equivalents & STI
- -
3,632
2,648
Accounts Receivable, Net
- -
2,934
2,753
Inventories
- -
191
171
Total Current Liabilities
- -
8,830
7,896
Payables & Accruals
- -
- -
- -
ST Debt
- -
4,030
3,924
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.98%
0.69%
2.63%
Free Cash Flow
-196.8%
29.78%
13.57%
Net Income, GAAP
-155.6%
-266.03%
1.09%
Sales/Revenue/Turnover
21.08%
6.48%
-3.2%
Total Cash Common Dividend
55.2%
-4.35%
-6.87%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,801
2,404
2,935
3,561
10,702
2025
1,754
2,355
- -
3,434
10,360
2026
1,584
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.07
- -
- -
- -
0.07
2025
-0.07
- -
- -
- -
0.07
2026
-0.07
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
- -
- -
- -
0.05
2025
0.01
- -
- -
- -
0.05
2026
0.01
- -
- -
- -
- -
Similar Companies
Ramsay Health Care Limited (RHC.AX)
Bumrungrad Hospital Public Company Limited (BZ7A.F)
Artra Group Corporation (6029.T)
Care Twentyone Corporation (2373.T)
Aier Eye Hospital Group Co., Ltd. (300015.SZ)
UCHIYAMA HOLDINGS Co.,Ltd. (6059.T)
Business
Meinian Onehealth Healthcare Holdings Co., Ltd. (002044.SZ) operates as China's leading provider of professional health examination and preventive healthcare services, offering comprehensive physical exams, health consultations, assessments, and interventions through an extensive network of centers. The company delivers core products including popular, high-end, and occupational health checkups such as physicals, blood tests, electrocardiograms, imaging diagnostics, genetic testing, and specialized AI-driven offerings like BrainRuijia for stroke screening, LungJingning for lung nodules, coronary artery calcium scoring, cognitive assessments, ECG analysis, breast ultrasound, fundus exams, pediatric bone age evaluation, and innovative AI traditional Chinese medicine physical exams; it also provides full-cycle health management via digital platforms including the Bian Que SAAS system, LIS laboratory management, PACS imaging systems, and the Health Little Meixue AI robot for blood sugar management and personalized digital twins. Meinian Onehealth manages prominent brands such as Mei Nian Da Health, Ci Ming Physical Examination, Ci Ming Oya, and Meizhao Health, alongside supplementary services in investment management, software development, pharmaceutical retail, financial leasing, and factoring. Founded in 2004 and headquartered in Shanghai, China, the company primarily serves individual consumers, group corporate clients, and government programs across the preventive medicine sector, employing over 38,000 staff and operating predominantly within China with a focus on digital transformation and AI integration to enhance efficiency and customer experience. In recent developments, Meinian Onehealth agreed in April 2025 to acquire a 90% stake in Feicheng Meinian OneHealth Management Co., Ltd. for CNY 26.2 million, issuing 4.8 million shares as consideration, with board and shareholder approvals secured by August 2025 to bolster its regional health management footprint; it cancelled a prior proposed acquisition of an 81% stake in Xiamen Yincheng Meinian OneHealth Management Co., Ltd., while renewing a genetic testing services framework with Mega Genomics in January 2024 and launching key AI products including the Health Little Meixue robot in August 2024 in partnership with Huawei Cloud and Shanghai Runda Medical Technology.